All In Biotech

Drug Trial Radar · NCT01090037

TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)

TRK-100STP PhaseIIb/III Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)

Last checked: Nov 20, 2026Latest source record: Feb 4, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 892 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

892

Actual

Start

Mar 2010

Primary completion

Aug 2014

Study completion Jan 2015

Sponsor

Lead sponsor
Toray Industries, IncIndustry
Sponsor type
Industry
Collaborators
Astellas Pharma Inc
First posted
Mar 19, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

In Chronic Renal Failure (CRF) patients with primary glomerular disease or nephrosclerosis as the primary disease: * To confirm the superiority of TRK-100STP over placebo * To determine the recommended therapeutic dose in the 2 doses of TRK-100STP * To assess the safety of TRK-100STP

Conditions

  • Chronic Renal Failure
  • Glomerular Disease
  • Nephrosclerosis

Interventions

  • TRK-100STP high doseDrug

  • TRK-100STP low doseDrug

  • PlaceboDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Renal composite endpoints [Time to first occurrence of one of the following events:]Time frame: 2-4 year

Locations

7 sites in 7 countries. Site status is shown where the registry gives one.

  • Site not named

    Beijing, China

  • Site not named

    Hong Kong, Hong Kong

  • Site not named

    Tokyo, Japan

  • Site not named

    Kuala Lumpur, Malaysia

  • Site not named

    Seoul, South Korea

  • Site not named

    Taipei, Taiwan

  • Site not named

    Bangkok, Thailand

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.